Cambridge Cognition Holdings Plc (LON:COG – Get Free Report)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 35.62 and traded as low as GBX 32.70. Cambridge Cognition shares last traded at GBX 32.70, with a volume of 7,690 shares.
Cambridge Cognition Stock Up 2.9%
The company has a debt-to-equity ratio of 29.16, a quick ratio of 0.96 and a current ratio of 0.40. The stock’s fifty day simple moving average is GBX 34.54 and its two-hundred day simple moving average is GBX 35.64. The company has a market capitalization of £17.73 million, a price-to-earnings ratio of -8.45 and a beta of 0.80.
About Cambridge Cognition
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Further Reading
- Five stocks we like better than Cambridge Cognition
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
